secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2025-01-02T23:59:59+00:00
Accession:  0001493152-25-000028
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic extends reverse merger deadline with Mosaic ImmunoEngineering to June 30, 2025
--------------------------------------------------------------------------------

- Term sheet dated April 26, 2024, originally 90-day term, extended to Dec 31, 2024; now extended to June 30, 2025.
- No definitive agreement reached; extension allows continued due diligence and documentation.
- Both companies mutually agreed extension is in best interests; transaction remains conditional and not guaranteed.
- Extension letter executed December 31, 2024; no other term sheet modifications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315225000028/0001493152-25-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315225000028/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer